Arcus Biosciences participated in an investor conference held in Boston on August 21, 2025.
1 report, 1 independent
Updated Aug 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Arcus Biosciences participated in an investor conference held in Boston on August 21, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arcus Biosciences
biopharmaceutical company
Nothing else this week.
-
Boston
capital and largest city of Massachusetts, United States
Related events
- Ligand Pharmaceuticals Incorporated participated in investor conferences in New York and Boston on August 26, 2026.
- Investor conferences are scheduled in Boston, and the company advises investors to follow updates via LinkedIn.
- Arcus Biosciences filed required reports with the Securities and Exchange Commission.
- CEO Jacek Olczak is scheduled to address investors at a conference in Boston.
Coverage
Newest first; wire copies grouped- Business WireArcus Biosciences to Participate in Three Upcoming Investor Conferences HAYWARD, Calif., August 20, 2025--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical co